THIRUMALAI CHEMICALS LTD.

Thirumalai Chemicals Limited (TCL) has released its Corporate Presentation for the quarter ended June 30, 2026 (Q1 FY27). The presentation, available on the company's website, provides an overview of the company's performance and strategic initiatives. The document includes a 'Safe Harbor' statement outlining forward-looking statements and associated risks. It also details TCL's historical evolution over five decades, from its founding in 1973 to its recent expansions, including a new Phthalic Anhydride and Fumaric Acid facility in Dahej in 2024 and an upcoming plant in the USA scheduled for 2025.

Thirumalai Chemicals Ltd announced that its Board of Directors has approved the raising of funds up to ₹750 crores through various instruments including debt and equity. The proceeds are intended for daily operations and refinancing existing debts. Additionally, the Board approved the sale of four windmills with a total installed capacity of 3.2 MW. The company also declared its un-audited financial results for the quarter ended June 30, 2026 (Standalone & Consolidated).

Thirumalai Chemicals Ltd announced that its Board of Directors has approved a proposal to raise funds up to ₹750 crores through various instruments including debt and equity. The funds are intended for day-to-day operations and debt repayment. Additionally, the Board approved the sale of four windmills with a total installed capacity of 3.2 MW. The company also declared its unaudited financial results for the quarter ended June 30, 2026, both standalone and consolidated, along with limited review reports.

Thirumalai Chemicals Ltd has received a show cause notice from the Commercial Tax Department, Ranipet, Tamil Nadu, under Section 73 of the CGST Act, 2017. The notice pertains to alleged output turnover and input tax discrepancies for the fiscal year 2022-23, with total dues (tax, interest, and penalty) amounting to ₹2292.66 lakhs (approximately ₹22.93 crore). The company believes the demands are erroneous and not sustainable, and expects any financial implication to be insignificant and not materially impact its financial position. A response will be submitted within the prescribed timelines.

Motilal Oswal Small Cap Fund, Motilal Oswal Multi Cap Fund, and Motilal Oswal BSE 1000 Index Fund, managed by Motilal Oswal Mutual Fund, have disposed of 1,51,245 shares, representing 0.1255% of the total equity, in Thirumalai Chemicals Ltd. The disposal occurred via market transactions on July 17, 2026. Following the sale, the combined holding of these schemes in Thirumalai Chemicals has reduced from 4.8903% to 4.7648%. The total equity share capital of the company remains unchanged at 12,05,52,774 shares.

Thirumalai Chemicals Limited has submitted its Business Responsibility & Sustainability Report (BRSR) for the financial year ended March 31, 2026. The report details the company's corporate identity, registered and corporate addresses, financial year, and stock exchange listings on BSE and NSE. It outlines business activities, primarily the manufacturing of petrochemicals (100% turnover), with Phthalic Anhydride and Derivatives, Malic Acid, and Fumaric Acid contributing 70.52% of turnover. The company operates 2 plants and 3 offices nationally, serving 28 states and 33 countries, with exports accounting for 14.29% of turnover. The report also includes employee statistics, detailing permanent and other than permanent employees and workers.

Thirumalai Chemicals Ltd has released its Annual Report for the Financial Year 2025-26, detailing its performance and strategic outlook. The report highlights the company's focus on expansion, innovation, and transformation, despite a challenging global economic environment. Key financial and ESG metrics for FY25-26 include total income of ₹1,393 crore, 1,03,049 KL of water recycled, 11,714 person hours of training, ₹20 crore in CSR spends supporting over 25,000 beneficiaries, and 1.96 crore KL of rainwater harvested. The company emphasizes its commitment to sustainable long-term value creation through major growth investments and expanded capacities.

Thirumalai Chemicals Ltd has announced the closure of its trading window for dealing in the company's equity shares. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from Wednesday, July 01, 2026, and will reopen 48 hours after the declaration of the Un-Audited Financial Results for the quarter ended June 30, 2026. This measure is standard practice to prevent potential insider trading during the period leading up to financial result announcements.

Thirumalai Chemicals Ltd. announced the approval of its audited financial results (standalone & consolidated) for the year ended March 31, 2026, during its board meeting held on May 30, 2026. The company's 53rd Annual General Meeting (AGM) is scheduled for August 7, 2026, via video conferencing. Additionally, the board approved the appointment of M/s. PKF Sridhar & Santhanam, LLP, as Statutory Auditors for a five-year term, subject to shareholder approval, succeeding M/s. Walker Chandiok & Co LLP after the 53rd AGM.

The Board of Directors of Thirumalai Chemicals Ltd approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The 53rd Annual General Meeting will be held on August 07, 2026, via video conferencing. M/s. PKF Sridhar & Santhanam, LLP, Chennai, were appointed as Statutory Auditors for five years, subject to shareholder approval, replacing M/s. Walker Chandiok & Co LLP after the 53rd AGM.